Luqa Pharma In-Licenses Scar Treatment from Stratpharma
04:27 EDT 3 Aug 2012 | ChinaBio Today
Luqa Pharmaceuticals, a Hong Kong company that specializes in dermatology products, has in-licensed exclusive China rights to Strataderm®, a scar treatment, from Stratpharma AG of Switzerland. Strataderm has already been approved by the SFDA;..
Original Article: Luqa Pharma In-Licenses Scar Treatment from Stratpharma
More From BioPortfolio on "Luqa Pharma In-Licenses Scar Treatment from Stratpharma"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
